Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00425230
(No patients were enrolled in this study. The study onset was delayed due to problems with drug acquisition.)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Chronic PLP > 6 months
Short-Form McGill Pain Questionnaire Sensory Pain Rating Index raw score ≥ 16
Age ≥ 18 years old
Inpatient or Outpatient
Able to come to all appointments, in the opinion of the investigator
Able to give informed consent, in opinion of investigator
Current Major Depressive disorder, Anxiety Disorder, or Psychotic disorder assessed by the Mini International Neuropsychiatric Interview (MINI)
Substance abuse or dependence within the last six months, as assessed by the MINI
Known Diabetes Mellitus to exclude diabetic peripheral neuropathy
History of coronary artery disease, hepatic disease, renal disease
Other pain syndromes
Any unstable medical conditions in the opinion of the investigator
Other psychotropic medications excluding hypnotics